NEW YORK (Reuters Health) - Gastric electrical stimulation using the Tantalus system (MetaCure Ltd) can potentially improve glucose control and induce weight loss in obese type 2 diabetic patients who are poorly controlled with oral antidiabetic medication, according to preliminary study results reported at the European Association for the Study of Diabetes in Rome.
